Drug
Hypericum perforatum clinical trials
- studies test it
- 8
- open now
- 0
- in phase 3
- 3
- first study started
- 1998
How studies write it
Studies that test it under each name
Development codes
Other names
Combined with it in one product
Studies by the year they started
7 studies that test it; most in 2002 (3)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2002 | 3 |
| 2005 | 1 |
| 2017 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 3
- Phase 4
- 1
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 7
National Center for Complementary and Integrative Health (NCCIH) (3) · Batman University (1) · Prof. Eldad Yechiam (1) · National Institute of Mental Health (NIMH) (1) · Cassella-med GmbH & Co. KG (1) · Alliance for Clinical Trials in Oncology (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Hypericum perforatum is read from its arms, and is right about nine times in ten.
Testing it · 8
- Comparison of Hypericum Perforatum, Topical Corticosteroids, and Hyaluronic Acid for Recurrent Aphthous StomatitisCompletedNot applicableBatman UniversityNCT06839313Written as Hypericum perforatum (St. John's wort oil, Zade Vital; Health&Fitness, Developed With Ege Üniversiesi Argefar)
- The Acute Effect of Hypericum Perforatum on Short-Term Memory in Healthy AdultsCompletedPhase 4Prof. Eldad YechiamNCT02862236Written as Hypericum perforatum extract
- Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryWithdrawnPhase 3Alliance for Clinical Trials in OncologyNCT00041171Written as Hypericum perforatum
- Treatment of Major Depression With St. John's Wort (Hypericum)CompletedNot applicableNational Institute of Mental Health (NIMH)NCT00005013Written as Hypericum perforatum (St. John's wort)
- St. John's Wort Extract LI 160 for the Treatment of Atypical DepressionCompletedPhase 3Cassella-med GmbH & Co. KGNCT00861978Written as St. John's Wort extract
- Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)CompletedPhase 2National Center for Complementary and Integrative Health (NCCIH)NCT00100295Written as Hypericum perforatum
- St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)CompletedPhase 2/3National Center for Complementary and Integrative Health (NCCIH)NCT00118833Written as Hypericum perforatum (St. John's wort)
- Effects of St. John's Wort on the Effectiveness of Oral ContraceptivesCompletedNot applicableNational Center for Complementary and Integrative Health (NCCIH)NCT00026013Written as hypericum perforatum
Codes
What other systems call Hypericum perforatum · ClinicalTrials.gg INT018473
- UNII (FDA) XK4IUX8MNBHYPERICUM PERFORATUM WHOLEConfirmed FDA, Wikidata
- RxNorm 258326One source FDA
- Wikidata Q158289Hypericum perforatumConfirmed FDA, Wikidata
- NCI Thesaurus C60535Hypericum perforatumOne source FDA
- DrugBank DB01323One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | XK4IUX8MNB | HYPERICUM PERFORATUM WHOLE | Confirmed FDA, Wikidata |
| RxNorm | 258326 | — | One source FDA |
| Wikidata | Q158289 | Hypericum perforatum | Confirmed FDA, Wikidata |
| NCI Thesaurus | C60535 | Hypericum perforatum | One source FDA |
| DrugBank | DB01323 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.